Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly Metcalfe

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
BMJ (Clinical Research Ed.)|February 13, 2014
Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysisKelly Metcalfe, Shelley Gershman, Parviz Ghadirian, et al.
Breast Cancer Research and Treatment|April 25, 2022
Risk factors for psychological morbidity and the protective role of coping self-efficacy in young women with breast cancer early in diagnosis: a national multicentre cohort studyDoris M Howell, Kelly Metcalfe, Shiying Kong, et al.
JAMA Oncology|July 17, 2015
Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation CarriersKelly Metcalfe, Henry T Lynch, William D Foulkes, et al.
Cancer|June 8, 2026
Clinicopathologic characteristics of early-onset breast cancer among unselected young Black womenHeather K Beasley, Tiana Shah, Rory J Tinker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2004
Contralateral breast cancer in BRCA1 and BRCA2 mutation carriersKelly Metcalfe, Henry T Lynch, Parviz Ghadirian, et al.
Cancer|October 13, 2004
A multicenter study of supportive-expressive group therapy for women with BRCA1/BRCA2 mutationsMary Jane Esplen, Jon Hunter, Molyn Leszcz, et al.
Bone Marrow Transplantation|November 21, 2019
Predictors of the trajectory of cognitive functioning in the first 6 months after allogeneic hematopoietic stem cell transplantationSamantha J Mayo, Hans A Messner, Sean B Rourke, et al.
Breast Cancer Research and Treatment|January 12, 2011
Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriersKelly Metcalfe, Henry T Lynch, Parviz Ghadirian, et al.
British Journal of Cancer|June 23, 2026
Frequency of germline pathogenic variants in breast cancer predisposing genes in a national cohort of young women with breast cancerKelly Metcalfe, Steven A Narod, Aletta Poll, et al.
Clinical Genetics|December 13, 2021
The risks of breast and ovarian cancer associated with the Ashkenazi Jewish founder allele BRCA2 6174delTAmy Finch, Kelly Metcalfe, Mohammad Akbari, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
BMJ (Clinical Research Ed.)|February 13, 2014
Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysisKelly Metcalfe, Shelley Gershman, Parviz Ghadirian, et al.
Breast Cancer Research and Treatment|April 25, 2022
Risk factors for psychological morbidity and the protective role of coping self-efficacy in young women with breast cancer early in diagnosis: a national multicentre cohort studyDoris M Howell, Kelly Metcalfe, Shiying Kong, et al.
JAMA Oncology|July 17, 2015
Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation CarriersKelly Metcalfe, Henry T Lynch, William D Foulkes, et al.
Cancer|June 8, 2026
Clinicopathologic characteristics of early-onset breast cancer among unselected young Black womenHeather K Beasley, Tiana Shah, Rory J Tinker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2004
Contralateral breast cancer in BRCA1 and BRCA2 mutation carriersKelly Metcalfe, Henry T Lynch, Parviz Ghadirian, et al.
Cancer|October 13, 2004
A multicenter study of supportive-expressive group therapy for women with BRCA1/BRCA2 mutationsMary Jane Esplen, Jon Hunter, Molyn Leszcz, et al.
Bone Marrow Transplantation|November 21, 2019
Predictors of the trajectory of cognitive functioning in the first 6 months after allogeneic hematopoietic stem cell transplantationSamantha J Mayo, Hans A Messner, Sean B Rourke, et al.
Breast Cancer Research and Treatment|January 12, 2011
Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriersKelly Metcalfe, Henry T Lynch, Parviz Ghadirian, et al.
British Journal of Cancer|June 23, 2026
Frequency of germline pathogenic variants in breast cancer predisposing genes in a national cohort of young women with breast cancerKelly Metcalfe, Steven A Narod, Aletta Poll, et al.
Clinical Genetics|December 13, 2021
The risks of breast and ovarian cancer associated with the Ashkenazi Jewish founder allele BRCA2 6174delTAmy Finch, Kelly Metcalfe, Mohammad Akbari, et al.
Pageof 8